Regulating Pharmaceutical Companies reach and influence on doctors and their prescription behavior.
AN ACT: To make sure that prescription behavior among doctors remains untainted by Pharmaceutical companies and preventing unethical marketing.
Be it enacted by the Youth Model Legislature of the State of New Jersey that pharmaceutical companies will no longer be allowed to go directly to healthcare providers and give them incentives to prescribe or treat a patient in any such way that would benefit said pharmaceutical company.
Section I: 1.Terms used in this act, unless context requires otherwise a.Prescription Drug- any drug that is available only through written instructions from a doctor to a pharmacist b.Treatments- solutions to ailments that offer alternatives i.I.e Dialysis, Chemotherapy, Radiation Therapy and Alt. Diets. c.Drug Companies- any maker or seller of pharmaceuticals d.Incentive- money or other such tangible things that hold value. Company-Sponsored Training- Training provided by a corporate body which is used to persuade professionals to prefer a certain action or outcome i. In the case of Pharmaceutical Companies, tell doctors to prescribe certain drugs or treatments. e.Form 10-Q-a legal document that must be filed with the Securities and Exchange Commission every quarter, which provides additional details behind the quarterly earnings report.
Section II: 1.Drug and Treatment Companies are prohibited from going to doctors with offers of money or other things of value with an intent of asking for a increase prescription rate or recommending certain treatments.
Section III 1.In order to regulate this, we will request Pharmaceutical Companies to submit reports on company-sponsored physician training and marketing directly to doctors and to publish these costs in their quarterly financial reports, or Form 10-Q
Section IV: 1.Drug Companies found in violation are to be fined $35,000 for every offense, and other punishment to be decided by a court. 2.Doctors are to be placed on a strike program and once infractions are of a certain amount, they will be fined $500 and too grow with every infraction after that. a. May lead to medical license to be revoked in the state of New Jersey.
This bill is planned to take effect as companies start to report their 10-Q forms and tax information.
Statement of Intent:
The intent of this bill is to decrease the rate of malpractice and incorrect prescription occurring in New Jersey caused by Pharmaceutical Companies. As well as to promote ethical marketing practices.
This bill is not to be treated as a way to penalize drug companies, but to give doctors the ability to provide better diagnoses for each patient.
Funds are to be allocated from initial fines. Providing a growing source of revenue.